These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 32443967)

  • 1. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
    Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
    Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
    Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
    Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma.
    Benadon B; Servagi-Vernat S; Quero L; Cattan P; Guillerm S; Hennequin V; Aparicio T; Lourenço N; Bouché O; Hennequin C
    Dig Liver Dis; 2020 Sep; 52(9):1047-1052. PubMed ID: 32493629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.
    Bongers MER; Groot OQ; Buckless CG; Kapoor ND; Twining PK; Schwab JH; Torriani M; Bredella MA
    Spine J; 2022 Apr; 22(4):595-604. PubMed ID: 34699994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
    Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
    Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
    Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
    BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy.
    Jang JY; Oh D; Noh JM; Sun JM; Kim HK; Shim YM
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1167-1176. PubMed ID: 38613258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC.
    Mallet R; Decazes P; Modzelewski R; Lequesne J; Vera P; Dubray B; Thureau S
    Sci Rep; 2021 May; 11(1):10628. PubMed ID: 34017035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Smee R; Moses D; Bauer J
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
    PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
    Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
    Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
    Özkul B; Özkul Ö; Bilir C
    Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis.
    Keshoofi P; Schindler P; Rennebaum F; Cordes F; Morgul H; Wildgruber M; Heinzow HS; Pascher A; Schmidt HH; Hüsing-Kabar A; Praktiknjo M; Trebicka J; Seifert LL
    BMC Gastroenterol; 2024 Apr; 24(1):145. PubMed ID: 38664624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sarcopenia, clinical data, and 2-[
    Anconina R; Ortega C; Metser U; Liu ZA; Suzuki C; McInnis M; Darling GE; Wong R; Taylor K; Yeung J; Chen EX; Swallow CJ; Bajwa J; Jang RW; Elimova E; Veit-Haibach P
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1012-1020. PubMed ID: 34491404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
    Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
    Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
    Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.